Zelicapavir
Respiratory Syncytial Virus (Rsv), Rsv Infection, Rsv
Phase II
Not Yet Recruiting
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus
Mar 16, 2026
―
Rosuvastatin, Midazolam, Caffeine, Edp-323
Drug Drug Interaction, Rsv Infection
Phase I
Completed
A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants
Apr 01, 2025
―
Carbamazepine, Itraconazole, Fluconazole, Quinidine, Edp-323
Drug Drug Interaction (Ddi), Rsv Infection
Phase I
Completed
A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.
Feb 21, 2025
―
Moxifloxacin, Zelicapavir
Rsv Infection, Qtc Interval
Phase I
Completed
A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults
Aug 27, 2024
―
Edp-323 Dose Regimen 1, Edp-323 Dose Regimen 2
Rsv Infection
Phase II
Completed
A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model
Nov 27, 2023
―
Edp-938
Rsv Infection
Phase II
Completed
A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.
Oct 03, 2022
―
Edp-938
Respiratory Syncytial Virus (Rsv)
Phase II
Completed
A Study to Evaluate EDP 938 Regimens in Children With RSV
Mar 23, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Enanta Pharmaceuticals (9EP) have in its pipeline
9EP is currently developing the following drugs: Zelicapavir, Rosuvastatin, Midazolam, Caffeine, Edp-323, Carbamazepine, Itraconazole, Fluconazole, Quinidine, Edp-323. These drug candidates are in various stages of clinical development as the company works toward FDA approval.